Marshall Posner

Physician · Cancer Center of South Florida Pllc

Credentials: · · · · · ·

History

The Tisch Cancer Institute - Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $1.1M · Icahn School of Medicine at Mount Sinai
2015–2025
Developing a Therapeutics Platform for Adenoid Cystic Carcinoma
National Institute of Dental and Craniofacial Research · R21
Contact PI · $466.1K · Icahn School of Medicine at Mount Sinai
2020–2023
EBV-Specific T-Cell Therapy for Nasopharynx Cancer: Immunomodulation and Response
National Cancer Institute · R21
Contact PI · $759.7K · Dana-Farber Cancer Inst
2008–2012
Functional Mechanisms of Antibody Inhibition of HIV-1
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.7M · Beth Israel Deaconess Medical Center
2004–2010

RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC
Principal investigator · Withdrawn · Phase 2
Icahn School of Medicine at Mount Sinai
2022
Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck
Principal investigator · Completed · Phase 1, Phase 2
Dana-Farber Cancer Institute
1997–2006
Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Principal investigator · Completed · Phase 2
Dana-Farber Cancer Institute
1997–2006
Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck
Principal investigator · Completed · Phase 1
Dana-Farber Cancer Institute
1995–2008